9 October 2020 - - US-based bioscience technology company VirTrial has been selected by biotechnology company BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) as their telehealth platform provider of choice, the company said.
The partnership will enable BetterLife to conduct remote patient monitoring for their imminent COVID-19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation.
BetterLife's decision to proceed with VirTrial was based on VirTrial platform's ability to satisfy three key selection criteria: the capability to work with their choice of sites, prioritize safety for their patients and site staff by mitigating COVID-19 risks, and facilitating an open consultation for patient qualification and consent.
A primary feature of the VirTrial platform that will be used during the study is virtual visits, a combination of secure video, audio, chat and messaging, which can be used on any device.
Incorporating virtual visits facilitates BetterLife to evaluate, qualify and routinely monitor both patients and research sites for studies without physical travel.
Unlike other clinical trial vendors that began as technology companies, VirTrial has a robust team of clinical research experts and knowledgeable tech entrepreneurs collaborating together to lead the company towards providing the human population with remote access to clinical research sites.
VirTrial is a bioscience technology company providing a stable, long-standing telemedicine platform to transform the clinical trial industry.
The VirTrial platform combines secure video, audio, chat and messaging allowing pharmaceutical companies and CROs to create patient centric Decentralized Clinical Trials (DCTs) by replacing some study visits with virtual visits.
The vision is for 25-50% of visits to be conducted virtually creating a hybrid model. The VirTrial platform is supported on any device (Android, Apple, tablet, phone, computer) and can be used by any site worldwide. They are hosted in a secure cloud-based environment and are HIPAA and GDPR compliant.
BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies.